Continuation of GLP-1 Receptor Agonist Use in Early Pregnancy Seems Safe

WEDNESDAY, June 10, 2026-- Continuation of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) into early pregnancy seems not to be associated with the risk for nonlive birth, abnormal fetal growth, or major congenital malformation (MCM)...